Please login to the form below
PMLiVE's Top Pharma list
This handy resource ranks the top companies in the pharmaceutical industry by their global sales, as well as by revenues in the US, Europe and Japan.
The Top Pharma List also features profile pages for each pharma company and additional rankings for biologic, cardiovascular, CNS, immunology, metabolic, ophthalmology, respiratory and oncology sales.
UPDATED JANUARY 2018
- Top 25 pharma companies by global sales
- Top 25 pharma companies in the US
- Top 20 pharma companies in Europe
- Top 15 pharma companies in Japan
- Top 25 pharma companies by biologic sales
- Top 20 pharma companies by cardiovascular sales
- Top 20 pharma companies by CNS sales
- Top 15 pharma companies by immunology sales
- Top 15 pharma companies by metabolic sales
- Top 10 pharma companies by opthalmology sales
- Top 10 pharma companies by respiratory sales
- Top 20 pharma companies by oncology sales
- Top 50 pharmaceutical products by global sales
- Methodology
The following pharmaceutical companies are featured in the current PMLiVE Top Pharma List:
- AbbVie
- Alexion
- ALK-Abello
- Allergan
- Almirall
- Amgen
- Astellas
- AstraZeneca
- Baxter
- Bayer
- Biogen Idec
- Bristol-Myers Squibb
- Celgene
- CSL
- Daiichi Sankyo
- Eisai
- Endo
- Gilead Sciences
- GlaxoSmithKline
- Incyte
- Jazz
- Johnson & Johnson
- Kyowa Hakko Kirin
- Lilly
- Lundbeck
- Mallinckrodt
- Merck & Co.
- Merck KGaA
- Mitsubishi Tanabe Pharma
- Mochida
- Nippon Shinyaku
- Novartis
- Novo Nordisk
- Ono
- Otsuka
- Pfizer
- Recordati
- Regeneron
- Roche
- Sanofi
- Santen
- Sawai
- Shionogi
- Shire
- Sumitomo Dainippon
- Takeda
- Teva
- UCB
- United Therapeutics
- Valeant
- Vertex
- Wockhardt
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Featured jobs
- Account Director or Senior Account Director
-
Salary TBC
-
Principal Medical Writer
-
£48 - 58, 000 according to skills and experience benefits
- Director of Scientific Services, Medical Communications, Six fig...
-
Six figure salary
- Account Manager– Medical Communications
-
(Negotiable - depending on experience)
- Senior Medical Writer, MedComms Agency
-
Salary TBC
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
-
Consultant
-
competitive salary
-
Vice President
-
Competitive Salary Offered
Subscribe to our email news alerts
- New coronavirus sees drug developers scramble to develop a vaccine
- Sanofi completes acquisition of immuno-oncology specialist Synthorx
- Immuno-oncology, personalised medicine continues to drive pharma sector
- Genital herpes vaccine candidate heads for human studies
- Roche’s SMA treatment risdiplam hits another clinical target
- Roche's checkpoint inhibitor fails pivotal urothelial cancer trial
- Aurora boosts team with new hires and internal promotions
- NICE knocks back J&J’s depression nasal spray Spravato
- Acceleron rockets on positive mid-stage pulmonary arterial hypertension data
- NIH starts first trial of an antibody for malaria prevention
- GSK licenses its tuberculosis vaccine to Gates MRI
- A snapshot of Congenica
No results were found
PMHub
Oxford University Press
Oxford University Press publishes over 100 prestigious, highly cited, and authoritative medical journals, many in collaboration with some of the...
Latest intelligence
- A snapshot of Congenica
- PME talks to CEO David Atkins...
- Data desires
- What are you looking to achieve with data and how are you preparing yourself to react to the results?...
- The balancing act that’s keeping pharma and biotech market access on its toes
- Pricing drugs and gaining reimbursement can be a real challenge for drug developers. Price it too high, and no one buys it. Price it too low, and it’s hard to...
Quick links
Infographics
